Lavaca Capital LLC Acquires New Position in Mettler-Toledo International Inc. (NYSE:MTD)

Lavaca Capital LLC bought a new position in Mettler-Toledo International Inc. (NYSE:MTD) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 150 shares of the medical instruments supplier’s stock, valued at approximately $210,000.

A number of other institutional investors have also recently made changes to their positions in the company. Bank of New York Mellon Corp lifted its position in Mettler-Toledo International by 169.4% in the 1st quarter. Bank of New York Mellon Corp now owns 573,702 shares of the medical instruments supplier’s stock valued at $763,764,000 after acquiring an additional 360,786 shares in the last quarter. PineStone Asset Management Inc. lifted its holdings in shares of Mettler-Toledo International by 127.4% during the second quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after purchasing an additional 145,453 shares in the last quarter. Capital International Investors raised its position in Mettler-Toledo International by 15.1% in the 1st quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock worth $1,431,696,000 after buying an additional 141,431 shares during the last quarter. Putnam Investments LLC lifted its stake in Mettler-Toledo International by 2,561.7% during the 4th quarter. Putnam Investments LLC now owns 67,555 shares of the medical instruments supplier’s stock valued at $81,941,000 after acquiring an additional 65,017 shares during the period. Finally, Point72 Asset Management L.P. boosted its holdings in shares of Mettler-Toledo International by 22,090.4% during the 4th quarter. Point72 Asset Management L.P. now owns 59,914 shares of the medical instruments supplier’s stock valued at $72,673,000 after acquiring an additional 59,644 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on MTD. JPMorgan Chase & Co. boosted their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a report on Monday, August 5th. Stifel Nicolaus increased their price target on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a “buy” rating in a report on Monday, August 5th. The Goldman Sachs Group raised their price target on Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 9th. StockNews.com upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Thursday, July 11th. Finally, Jefferies Financial Group reissued an “underperform” rating and issued a $1,250.00 target price (up from $1,230.00) on shares of Mettler-Toledo International in a research report on Monday, June 3rd. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and an average target price of $1,356.25.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 250 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total value of $350,250.00. Following the completion of the transaction, the chief financial officer now directly owns 4,914 shares in the company, valued at approximately $6,884,514. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Shawn Vadala sold 250 shares of the firm’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total value of $350,250.00. Following the completion of the transaction, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at $6,884,514. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Christian Magloth sold 1,000 shares of the business’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the completion of the sale, the insider now owns 734 shares in the company, valued at $1,044,459.98. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,406.11 on Friday. The business’s fifty day moving average is $1,408.63 and its 200 day moving average is $1,375.76. Mettler-Toledo International Inc. has a fifty-two week low of $928.49 and a fifty-two week high of $1,546.93. The company has a market capitalization of $30.03 billion, a PE ratio of 39.43, a price-to-earnings-growth ratio of 3.70 and a beta of 1.14.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, topping the consensus estimate of $9.00 by $0.65. The firm had revenue of $946.75 million for the quarter, compared to the consensus estimate of $929.13 million. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. The business’s revenue for the quarter was down 3.6% compared to the same quarter last year. During the same quarter last year, the company earned $10.19 earnings per share. On average, sell-side analysts forecast that Mettler-Toledo International Inc. will post 40.35 EPS for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.